INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Universidad de La Frontera
Temuco, ChilePublicaciones en colaboración con investigadores/as de Universidad de La Frontera (6)
2019
-
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 121-130
-
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet, Vol. 394, Núm. 10193, pp. 131-138
-
Fatigue in U12 Soccer-7 Players During Repeated 1-Day Tournament Games-A Pilot Study
Journal of strength and conditioning research, Vol. 33, Núm. 11, pp. 3092-3097
2017
-
Heart rate, technical performance, and session-RPE in elite youth soccer small-sided games played with wildcard players
Journal of Strength and Conditioning Research, Vol. 31, Núm. 10, pp. 2678-2685
-
Rivaroxaban with or without aspirin in stable cardiovascular disease
New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330
2011
-
A linear regression model can estimate hip fracture incidence
Archives of Osteoporosis